argenx SE | ARGX - Capital Social e Reservas





Capital Social e Reservas Alterar Data
AstraZeneca USD 47.33B 1.33B 2026-03
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Qiagen NV USD 3.33B 446.45M 2026-03
UCB EUR 10.87B 1.18B 2025-12